David Hallal - 13 Jun 2023 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Director
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
Issuer symbol
ITOS
Transactions as of
13 Jun 2023
Transactions value $
$0
Form type
4
Filing time
15 Jun 2023, 19:54:10 UTC
Previous filing
12 May 2023
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITOS Stock Option (Right to Buy) Award $0 +22,383 $0 22,383 13 Jun 2023 Common Stock 22,383 $14.77 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.